Poorly managed pain creates an enormous burden on our healthcare system and produces tremendous human suffering. Following an injury, pain is caused by the production of inflammatory cytokines that induce changes in the excitability of nociceptor neurons. A better understanding of molecular mechanisms that facilitate nociceptor plasticity is vital for improved pain treatment. Post-transcriptional gene control has emerged as a dominant theme in pain induced plasticity. We focus on Poly(A) binding proteins (PABPs), a conserved family of 3? end associated factors that regulate translation initiation and play prominent roles in development and memory. We will determine binding specificities for PABPs present in dorsal root ganglion (DRG) neurons using an unbiased next- generation sequencing approach. This information will be used to generate a novel class of chemically stabilized RNAs called specificity-derived competitive inhibitor oligonucleotides (SPOT-ONs). Unlike genome editing or RNA interference, SPOT-ONs are well tolerated and bypass the need for host-factors as they function as ?decoys?. A major advantage of pharmacological inhibition as opposed to targeted gene disruption is the ability to simultaneously impair multiple homologues in a larger gene family. Our preliminary findings indicate that a bi- specific PABP SPOT-ON provides robust anti-hyperalgesic effects in vivo. Based on this finding, we hypothesize that PABPs are crucial mediators of plasticity in nociceptors. We describe preliminary development of SPOT- ONs which reduce protein synthesis in nociceptors and act specifically on poly(A)-mediated mRNA translation (Aim 1). We probe PABP mechanism of action through examination of localized translation and global identification of targets in nociceptors (Aim 2). Finally, we determine how PABP inhibition impacts nociceptor excitability and behavioral responses to injury (Aim 3).
Poorly managed pain creates an enormous burden on our healthcare system and produces tremendous human suffering. Limited treatment strategies have resulted in an opioid epidemic. This research investigates molecular and behavioral impacts of targeted inhibition of a conserved family of translation factors as potential targets for pain treatment.
|Zhou, Qin; Kunder, Nikesh; De la Paz, José Alberto et al. (2018) Global pairwise RNA interaction landscapes reveal core features of protein recognition. Nat Commun 9:2511|
|Megat, Salim; Ray, Pradipta R; Moy, Jamie K et al. (2018) Nociceptor translational profiling reveals the Ragulator-Rag GTPase complex as a critical generator of neuropathic pain. J Neurosci :|
|Black, Bryan J; Atmaramani, Rahul; Kumaraju, Rajeshwari et al. (2018) Adult mouse sensory neurons on microelectrode arrays exhibit increased spontaneous and stimulus-evoked activity in the presence of interleukin-6. J Neurophysiol 120:1374-1385|
|de la Peña, June Bryan; Campbell, Zachary T (2018) RNA-binding proteins as targets for pain therapeutics. Neurobiol Pain 4:2-7|
|Barragán-Iglesias, Paulino; Lou, Tzu-Fang; Bhat, Vandita D et al. (2018) Inhibition of Poly(A)-binding protein with a synthetic RNA mimic reduces pain sensitization in mice. Nat Commun 9:10|
|Lou, Tzu-Fang; Weidmann, Chase A; Killingsworth, Jordan et al. (2017) Integrated analysis of RNA-binding protein complexes using in vitro selection and high-throughput sequencing and sequence specificity landscapes (SEQRS). Methods 118-119:171-181|